Cardiovascular diseases in kidney transplant recipients: The role of anemia

Advances in Chronic Kidney Disease

Volumn 11, Issue 3, 2004, Pages 328-333

  Kadambi, Pradeep V ^a   Javaid, Basit ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

anemia; cardiovascular diseases; congestive heart failure; ischemic heart disease; Kidney transplantation

Indexed keywords

ANEMIA; CARDIOVASCULAR DISEASE; DEATH; GRAFT REJECTION; HEART INFARCTION; HUMAN; KIDNEY TRANSPLANTATION; MORTALITY; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK FACTOR;

EID: 3242707794     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.arrt.2004.04.003     Document Type: Article

References (25)

1. U.S. Renal Data System, USRDS 2003 Annual Data Report. Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD:2003
2. Ojo A.O., Hanson J.A., Wolfe R.A., et al. Long-term survival in renal transplant recipients with graft function. Kidney Int. 57:2000;307-313
3. Hariharan S., Johnson C.P., Bresnahan B.A., et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 342:2000;605-612
4. Sarnak M.J., Tighiouart H., Manjunath G., et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol. 40:2002;27-33
5. Al-Ahmad A., Rand W.M., Manjunath G., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 38:2001;955-962
6. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 108:2003;2154-2269
7. Gill J.S., Pereira B.J. Chronic kidney disease and the transplant recipient. Blood Purif. 21:2003;137-142
8. Rigatto C., Parfrey P., Foley R., et al. Congestive heart failure in renal transplant recipients Risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol. 13:(4):2002;1084-1090
9. Rigatto C., Foley R., Jeffery J., et al. Electrocardiographic left ventricular hypertrophy in renal transplant recipients Prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol. 14:2003;. 462-48
10. Djamali A., Becker Y.T., Simmons W.D., et al. Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients. Transplantation. 76:2003;816-820
11. Abbott K.C., Hypolite I.O., Hshieh P., et al. Hospitalized congestive heart failure after renal transplantation in the United States. Ann Epidemiol. 12:2002;115-122
12. Abbott K.C., Bucci J.R., Cruess D., et al. Graft loss and acute coronary syndromes after renal transplantation in the United States. J Am Soc Nephrol. 13:2002;2560-2569
13. Mix T.C., Kazmi W., Khan S., et al. Anemia A continuing problem following kidney transplantation. Am J Transplant. 3:2003;1426-1433
14. Yorgin P.D., Scandling J.D., Belson A., et al. Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem? Am J Transplant. 2:2002;429-435
15. Kim H.C., Park S.B., Han S.Y., et al. Anemia following renal transplantation. Transplant Proc. 35:2003;302-303
16. Karthikeyan V., Karpinski J., Nair R.C., et al. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant. 4:2004;262-269
17. Vanrenterghem Y., Ponticelli C., Morales J.M., et al. Prevalence and management of anemia in renal transplant recipients A European survey. Am J Transplant. 3:2003;835-845
18. Ponticelli C., Villa M. Role of anaemia in cardiovascular mortality and morbidity in transplant patients. Nephrol Dial Transplant. 17:(suppl 1):2002;41-46
19. Kiberd B., Keough-Ryan T., Panek R. Cardiovascular disease reduction in the outpatient kidney transplant clinic. Am J Transplant. 3:2003;1393-1399
20. Silverberg D.S., Wexler D., Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail. 4:(6):2002;681-686
21. Metivier F., Marchais S.J., Guerin A.P., et al. Pathophysiology of anaemia Focus on the heart and blood vessels. Nephrol Dial Transplant. 15:(suppl 3):2000;14-18
22. Besarab A., Bolton W.K., Browne J.K., et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 339:1998;584-590
23. Collins A.J. Anaemia management prior to dialysis Cardiovascular and cost-benefit observations. Nephrol Dial Transplant. 18:(suppl 2):2003;2-6
24. Macdougall I.C. Steering Committee of the CREATE trial, CREATE Study Group. CREATE new strategies for early anemia management in renal insufficiency. Nephrol Dial Transplant. 18:(suppl 2):2003;13-16
25. Roger S.D., McMahon L.P., Clarkson A., et al. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4) Results of a randomized clinical trial. J Am Soc Nephrol. 15:2004;148-156